Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
32
Number of overlapping holdings
16.7%
% of IBB's 212 holdings also in IDNA
71.1%
% of IDNA's 49 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 9.9% | 5.9% | 5.9% |
|
REGENERON PHARMACEUTICALS | 5.3% | 3.1% | 3.1% |
 |
BIONTECH SE SPONSORED ADR | 2.5% | 5.0% | 2.5% |
|
INCYTE CORP | 1.3% | 4.9% | 1.3% |
|
MODERNA, INC. | 1.5% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IDNA
|
VERTEX PHARMACEUTICALS INC | 8.0% |
|
AMGEN INC | 6.9% |
|
GILEAD SCIENCES INC | 4.0% |
|
IQVIA HOLDINGS INC | 3.7% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
 |
ARGENX SE ADR | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
ILLUMINA INC | 2.3% |
|
WATERS CORP | 2.3% |
|
REGENERON PHARMACEUTICALS | 2.2% |
IBB Underweight Relative to IDNA
|
EXELIXIS INC | -5.7% |
 |
BEIGENE, LTD. | -4.8% |
|
ROCHE HOLDING LTD | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
|
REVOLUTION MEDICINES, INC. | -4.1% |
 |
SANOFI-AVENTIS | -4.0% |
|
ARCELLX, INC. | -3.6% |
|
INCYTE CORP | -3.5% |
 |
GSK PLC | -3.4% |
|
MERCK & CO. INC. | -3.3% |